China's Innovent Biologics signs drug deal with Pfizer worth up to $10.5bn
Geopolitics Nikkei Asia May 29, 2026
China's Innovent Biologics signs drug deal with Pfizer worth up to $10.5bn
China's Innovent Biologics signs drug deal with Pfizer worth up to $10.5bn
Geopolitics Nikkei Asia May 29, 2026